Retrospective Evaluation of Clinical Experience With Intravenous Ascorbic Acid in Patients With Cancer
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Retrospective Evaluation of Clinical Experience With Intravenous Ascorbic Acid in Patients With Cancer
Authors
Keywords
-
Journal
INTEGRATIVE CANCER THERAPIES
Volume -, Issue -, Pages 153473541877580
Publisher
SAGE Publications
Online
2018-05-17
DOI
10.1177/1534735418775809
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Mechanisms of anti-cancer effects of ascorbate: Cytotoxic activity and epigenetic modulation
- (2018) Domenico Mastrangelo et al. BLOOD CELLS MOLECULES AND DISEASES
- Total, Dietary, and Supplemental Vitamin C Intake and Risk of Incident Kidney Stones
- (2016) Pietro Manuel Ferraro et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Synergistic effects of ascorbate and sorafenib in hepatocellular carcinoma: New insights into ascorbate cytotoxicity
- (2016) Lauren Rouleau et al. FREE RADICAL BIOLOGY AND MEDICINE
- Double-blind, randomized crossover study of intravenous infusion of magnesium sulfate versus 5% dextrose on depressive symptoms in adults with treatment-resistant depression
- (2016) Syed M. A. Mehdi et al. PSYCHIATRY AND CLINICAL NEUROSCIENCES
- High-Dose Intravenous Vitamin C Combined with Cytotoxic Chemotherapy in Patients with Advanced Cancer: A Phase I-II Clinical Trial
- (2015) L. John Hoffer et al. PLoS One
- Elimination of Ascorbic Acid After High-Dose Infusion in Prostate Cancer Patients: A Pharmacokinetic Evaluation
- (2014) Torben K. Nielsen et al. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY
- Intravenous Vitamin C and Cancer
- (2014) Heidi Fritz et al. INTEGRATIVE CANCER THERAPIES
- High-Dose Parenteral Ascorbate Enhanced Chemosensitivity of Ovarian Cancer and Reduced Toxicity of Chemotherapy
- (2014) Y. Ma et al. Science Translational Medicine
- Pharmacological ascorbate with gemcitabine for the control of metastatic and node-positive pancreatic cancer (PACMAN): results from a phase I clinical trial
- (2013) J. L. Welsh et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Phase I clinical trial to evaluate the safety, tolerability, and pharmacokinetics of high-dose intravenous ascorbic acid in patients with advanced cancer
- (2013) Christopher M. Stephenson et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Ascorbate Induces Ten-Eleven Translocation (Tet) Methylcytosine Dioxygenase-mediated Generation of 5-Hydroxymethylcytosine
- (2013) Emily A. Minor et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- A Convenient Method for Measuring Blood Ascorbate Concentrations in Patients Receiving High-Dose Intravenous Ascorbate
- (2013) Yan Ma et al. JOURNAL OF THE AMERICAN COLLEGE OF NUTRITION
- Ascorbic Acid Supplements and Kidney Stone Incidence Among Men: A Prospective Study
- (2013) Laura D. K. Thomas et al. JAMA Internal Medicine
- Phase I Evaluation of Intravenous Ascorbic Acid in Combination with Gemcitabine and Erlotinib in Patients with Metastatic Pancreatic Cancer
- (2012) Daniel A. Monti et al. PLoS One
- Vitamin C: Intravenous Use by Complementary and Alternative Medicine Practitioners and Adverse Effects
- (2010) Sebastian J. Padayatty et al. PLoS One
- Oxalic acid excretion after intravenous ascorbic acid administration
- (2009) Line Robitaille et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Phase I clinical trial of i.v. ascorbic acid in advanced malignancy
- (2008) L. J. Hoffer et al. ANNALS OF ONCOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started